US EditionPublished • loading... • Updated
Conexus CEO: AI momentum in pharma isn’t slowing, but maturity is uneven
Summary by Research & Development World
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Conexus CEO: AI momentum in pharma isn’t slowing, but maturity is uneven
Pharma and biotech are fielding AI pilots across discovery, clinical and commercial, but the gains still hinge on having the right plumbing, culture and talent. That means integrated platforms, governed data, and trained users. The harder truth: AI tends to magnify dysfunction rather than fix it. This foundational work is especially vital when AI-driven recommendations… The post Conexus CEO: AI momentum in pharma isn’t slowing, but maturity is u…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
